SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-022863
Filing Date
2021-05-03
Accepted
2021-05-03 17:15:18
Documents
3
Period of Report
2021-05-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20210503.htm 8-K 34201
2 EX-99.1 abio-ex991_6.htm EX-99.1 10656
3 GRAPHIC g3qwffbahdib000001.jpg GRAPHIC 20861
  Complete submission text file 0001564590-21-022863.txt   75169
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 21884652
SIC: 2835 In Vitro & In Vivo Diagnostic Substances